Skip to NavigationSkip to content

News

Gilead’s impending regulatory submission of its JAK inhibitor filgotinib to the FDA for the treatment of rheumatoid arthritis has been marred by...
The Biotechnology and Biological Sciences Research Council (BBSRC) and UK Research and Innovation (UKRI) have awarded a funding injection of £170...
This growth is predicted to be driven predominantly by adoption of maintenance therapy for the disease across the US, UK, France, Germany, Spain,...
A total of 387 establishments were forcibly closed in the country’s Benue State, corresponding to 44 pharmacies and 343 patent medicine shops....
Astellas has revealed that the European Commission has awarded marketing approval for Xospata as an oral, once-daily monotherapy for the treatment...
It's another end of the week here at Pharmafile and here we run down our top 10 articles and features you've been reading in the past seven days....
BioSciences in the UK has received a massive boost of £18.5 million awarded from the Biotechnology and Biological Sciences Research Council (BBSRC),...
Biogen is planning to seek approval for its experimental drug aducanumab, that could potentially be first to treat Alzheimer’s and be the first drug...
FlyPharma's two-day conference aimed to discuss the collaboration and growth within Scandinavia, with a special focus on women in pharmaceutical...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches